These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12233987)

  • 1. Multimodal evaluation of risperidone for destructive behavior: functional analysis, direct observations, rating scales, and psychiatric impressions.
    Valdovinos MG; Napolitano DA; Zarcone JR; Hellings JA; Williams DC; Schroeder SR
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):268-75. PubMed ID: 12233987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
    Research Units on Pediatric Psychopharmacology Autism Network
    Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of functional analysis methodology in the evaluation of medication effects.
    Crosland KA; Zarcone JR; Lindauer SE; Valdovinos MG; Zarcone TJ; Hellings JA; Schroeder SR
    J Autism Dev Disord; 2003 Jun; 33(3):271-9. PubMed ID: 12908830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis.
    Zarcone JR; Lindauer SE; Morse PS; Crosland KA; Valdovinos MG; McKerchar TL; Matthew Reese R; Hellings JA; Schroeder SR
    Am J Ment Retard; 2004 Jul; 109(4):310-21. PubMed ID: 15176916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures.
    Zarcone JR; Hellings JA; Crandall K; Reese RM; Marquis J; Fleming K; Shores R; Williams D; Schroeder SR
    Am J Ment Retard; 2001 Nov; 106(6):525-38. PubMed ID: 11708938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ; Holmes JP; Carlson DC; Pelton GH; Cohen DJ; Price LH
    Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do I decide whether or not to use medication for my child with autism? Should I try behavior therapy first?
    Scahill L
    J Autism Dev Disord; 2008 Jul; 38(6):1197-8. PubMed ID: 18463973
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
    Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
    Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
    McDougle CJ; Scahill L; Aman MG; McCracken JT; Tierney E; Davies M; Arnold LE; Posey DJ; Martin A; Ghuman JK; Shah B; Chuang SZ; Swiezy NB; Gonzalez NM; Hollway J; Koenig K; McGough JJ; Ritz L; Vitiello B
    Am J Psychiatry; 2005 Jun; 162(6):1142-8. PubMed ID: 15930063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.
    Hellings JA; Zarcone JR; Crandall K; Wallace D; Schroeder SR
    J Child Adolesc Psychopharmacol; 2001; 11(3):229-38. PubMed ID: 11642473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone in children with autism and serious behavioral problems.
    McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D;
    N Engl J Med; 2002 Aug; 347(5):314-21. PubMed ID: 12151468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone-induced double incontinence.
    Hergüner S; Mukaddes NM
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1085-6. PubMed ID: 18387724
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities.
    Buitelaar JK; van der Gaag RJ; Cohen-Kettenis P; Melman CT
    J Clin Psychiatry; 2001 Apr; 62(4):239-48. PubMed ID: 11379837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open clinical trial of risperidone monotherapy in young children with autistic disorder.
    Findling RL; Maxwell K; Wiznitzer M
    Psychopharmacol Bull; 1997; 33(1):155-9. PubMed ID: 9133768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of risperidone on aberrant behavior in persons with developmental disabilities: II. Social validity measures.
    McAdam DB; Zarcone JR; Hellings J; Napolitano DA; Schroeder SR
    Am J Ment Retard; 2002 Jul; 107(4):261-9. PubMed ID: 12069645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems.
    Carroll D; Hallett V; McDougle CJ; Aman MG; McCracken JT; Tierney E; Arnold LE; Sukhodolsky DG; Lecavalier L; Handen BL; Swiezy N; Johnson C; Bearss K; Vitiello B; Scahill L
    Child Adolesc Psychiatr Clin N Am; 2014 Jan; 23(1):57-72. PubMed ID: 24231167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.
    Bruggeman R; van der Linden C; Buitelaar JK; Gericke GS; Hawkridge SM; Temlett JA
    J Clin Psychiatry; 2001 Jan; 62(1):50-6. PubMed ID: 11235929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone for aggression and self-injurious behavior in adults with mental retardation.
    Cohen SA; Ihrig K; Lott RS; Kerrick JM
    J Autism Dev Disord; 1998 Jun; 28(3):229-33. PubMed ID: 9656134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind pilot study of risperidone in the treatment of conduct disorder.
    Findling RL; McNamara NK; Branicky LA; Schluchter MD; Lemon E; Blumer JL
    J Am Acad Child Adolesc Psychiatry; 2000 Apr; 39(4):509-16. PubMed ID: 10761354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.
    Khan BU
    J Autism Dev Disord; 1997 Aug; 27(4):479-89. PubMed ID: 9261670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.